- Stocks
- Pharma & Healthcare
- DECIPHER LABS
DECIPHER LABS share price
NSE: DECIPHERPharma & HealthcareDrug Manufacturers - Specialty & Generic
DECIPHER LABS at a glance
With a market capitalisation of ₹6 Cr, it ranks 4040th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.
Its return on equity was −37.4% in FY26. Promoters held 16.43% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹6 CrRank 4040 on NSE
- Price to book
- 0.61×FY26
- ROE
- −37.4%FY26
- ROCE
- −44.7%FY26
- Debt to equity
- 0.06FY26
- Net profit margin
- −21.9%FY26
- Book value / share
- ₹8.16FY26
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
DECIPHER LABS financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹56 Cr | ₹65 Cr | ₹46 Cr | ₹36 Cr | ₹23 Cr | — |
| Operating profit | ₹2 Cr | ₹12 Cr | −₹2 Cr | −₹1 Cr | −₹6 Cr | — |
| Net profit | ₹1 Cr | ₹11 Cr | −₹3 Cr | −₹2 Cr | −₹5 Cr | — |
| EPS (₹) | ₹1.00 | ₹11.00 | −₹3.00 | −₹2.00 | −₹5.00 | — |
| Cash from operations | ₹2 Cr | ₹8 Cr | −₹2 Cr | ₹5 Cr | −₹10 Cr | — |
| Total debt | ₹7 Cr | ₹7 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹14 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹23 Cr | ₹8 Cr |
DECIPHER LABS shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% |
| Foreign institutions | — | — | — | — | 0.00% | 0.00% |
| Non-institutions | 83.57% | 83.57% | 83.57% | 83.57% | 83.57% | 83.57% |
DECIPHER LABS vs peers
The listed Pharma & Healthcare companies nearest to DECIPHER LABS by market capitalisation.
Ask anything about DECIPHER LABS
Pivot answers on the live chart with evidence you can check, and tests strategies against DECIPHER's own history. Try: “Why has DECIPHER moved over the last three months?” · “Backtest a 50-day moving-average crossover on DECIPHER over five years” · “Compare DECIPHER with TRINITYLEA on margins and valuation”
Frequently asked questions about DECIPHER LABS
What is the market cap of DECIPHER LABS?
DECIPHER LABS's market capitalisation is ₹6 Cr (₹6 Cr) at the 22 Oct 2026 close, ranking 4040th among the NSE companies Pivot tracks.
What is the ROE and ROCE of DECIPHER LABS?
Return on equity was −37.4% in FY26 and return on capital employed was −44.7% in FY26 (consolidated figures).
Is DECIPHER LABS a debt-free company?
No. DECIPHER LABS's debt-to-equity ratio was 0.06 in FY26, with total debt of ₹0 Cr.
What is the shareholding pattern of DECIPHER LABS?
As of 30 Jun 2026: promoters 16.43%, foreign institutions 0.00%, non-institutions 83.57%.
Who are DECIPHER LABS's competitors?
The listed Pharma & Healthcare companies closest to DECIPHER LABS by market cap are Trinity League, Adline Chem Lab, Unjha Formula, Dr Lalchandani, Vivanza Bio and Evoq Remedies.
Is DECIPHER LABS a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out DECIPHER LABS's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on DECIPHER against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with D · all NSE stocks · this page as text